Showing results (21-30 of 40) with videos related to
Sort By:
Pageof 4
Anticancer Research|May 30, 2008
Antitumoral and antiangiogenic efficacy of bisphosphonates in vitro and in a murine RENCA modelJens Soltau, Ute Zirrgiebel, Norbert Esser, et al.Anticancer Research|July 28, 2004
Antiangiogenic potency of various chemotherapeutic drugs for metronomic chemotherapyJoachim Drevs, Julia Fakler, Silke Eisele, et al.Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|January 15, 2005
Intravitreal injection of specific receptor tyrosine kinase inhibitor PTK787/ZK222 584 improves ischemia-induced retinopathy in micePhilip Maier, Anke S Unsoeld, Bernd Junker, et al.International Journal of Oncology|April 11, 2009
AMT: preclinical pharmacology studiesFaiz Niazi, Joachim Drevs, Klaus Diergarten, et al.European Urology|June 14, 2008
Mode-of-action, efficacy, and safety of a homologous multi-epitope vaccine in a murine model for adjuvant treatment of renal cell carcinomaChristian Doehn, Norbert Esser, Hans-Gerd Pauels, et al.Oncology Reports|December 4, 2009
Anti-tumor effects of AMT in the renal cell carcinoma modelMarcello Caballero, Jürgen Scheele, Ute Zirrgiebel, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|December 25, 2002
Implications of vascular endothelial growth factor, sFlt-1, and sTie-2 in plasma, serum and cerebrospinal fluid during cerebral ischemia in manKai-Michael Scheufler, Joachim Drevs, Vera van Velthoven, et al.Cancer Research|July 23, 2003
A new approach for the treatment of malignant melanoma: enhanced antitumor efficacy of an albumin-binding doxorubicin prodrug that is cleaved by matrix metalloproteinase 2Ahmed M Mansour, Joachim Drevs, Norbert Esser, et al.Onkologie|December 8, 2007
Metronomic antiangiogenic therapy with capecitabine and celecoxib in advanced tumor patients--results of a phase II studySimone Steinbild, Jann Arends, Michael Medinger, et al.Seminars in Oncology|June 13, 2003
Vascular endothelial growth factor receptor tyrosine kinase inhibitors: PTK787/ZK 222584Anne L Thomas, Bruno Morgan, Joachim Drevs, et al.Pageof 4